![Robert G. Boyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert G. Boyle
Fondateur chez
Sentinel Oncology Ltd.
Profil
Mr. Robert G.
Boyle is a Chief Executive Officer & Director at Sentinel Oncology Ltd. and an Advisor at o2h Ltd. He is on the Board of Directors at Sentinel Oncology Ltd. Mr. Boyle was previously employed as a Principal by Astex Technology Ltd., a Principal by Takeda Oncology Co., a Principal by Cambridge Discovery Chemistry, and a Principal by Pfizer Ltd.
Postes actifs de Robert G. Boyle
| Sociétés | Poste | Début |
|---|---|---|
Sentinel Oncology Ltd.
 Sentinel Oncology Ltd. BiotechnologyHealth Technology Operates as a small molecule drug discovery company | Fondateur | 01/01/2005 |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de Robert G. Boyle
| Sociétés | Poste | Fin |
|---|---|---|
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Corporate Officer/Principal | 01/01/2005 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/01/2003 |
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Provides chemistry research services | Corporate Officer/Principal | 01/01/2000 |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Corporate Officer/Principal | 01/01/1997 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Provides chemistry research services | Commercial Services |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
Sentinel Oncology Ltd.
Sentinel Oncology Ltd. BiotechnologyHealth Technology Operates as a small molecule drug discovery company | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
